Cargando…

The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran

BACKGROUND: Elevation of low-density lipoprotein cholesterol (LDL-c) is still a hugely unmet need in the reduction of atherosclerotic cardiovascular disease. In the published CardioRisk project in Egypt, up to 71% of female participants had dyslipidemia. Control of LDL-c levels and thus improvement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elserafy, Ahmed Shawky, Bendary, Ahmed, Elbahry, Atef, Farag, Elsayed, Mostafa, Tamer, Sanad, Osama, Elkersh, Ahmed, Selim, Mohammed, Ragy, Hany, Khamis, Hazem, Abdo, Waleed, Reda, Ashraf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652189/ https://www.ncbi.nlm.nih.gov/pubmed/36053454 http://dx.doi.org/10.1007/s40119-022-00277-3

Ejemplares similares

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
por: Reda, Ashraf, et al.
Publicado: (2020)

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction
por: Elserafy, Ahmed S., et al.
Publicado: (2021)

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndrome: final data of the nationwide cross-sectional ‘CardioRisk’ project
por: Reda, Ashraf, et al.
Publicado: (2021)

Inclisiran: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2020)

Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long‐Term Registry
por: Hassanein, Mahmoud, et al.
Publicado: (2018)

Safety and efficacy outcomes at 1 year after MitraClip therapy for percutaneous mitral valve repair in patients with severe mitral regurgitation: the Egyptian experience
por: Elbelbesy, Radwa Abdullah, et al.
Publicado: (2021)

Correction to: Inclisiran: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

Clinical characteristics and management of hospitalized and ambulatory patients with heart failure–results from ESC heart failure long‐term registry–Egyptian cohort
por: Hassanein, Mahmoud, et al.
Publicado: (2015)

A case series of ischemic stroke with coronavirus disease 2019 in two Egyptian centers
por: El Nahas, Nevine, et al.
Publicado: (2020)

The predictive value of precipitating factors on clinical outcomes in hospitalized patients with decompensated heart failure: insights from the Egyptian cohort in the European Society of Cardiology Heart Failure long-term registry
por: Bendary, Ahmed, et al.
Publicado: (2023)

Correction: The predictive value of precipitating factors on clinical outcomes in hospitalized patients with decompensated heart failure: insights from the Egyptian cohort in the European Society of Cardiology Heart Failure long-term registry
por: Bendary, Ahmed, et al.
Publicado: (2023)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis
por: Rogula, Sylwester, et al.
Publicado: (2021)

Inclisiran: a novel drug for the treatment of dyslipidemia
por: Nadeem, Abdullah, et al.
Publicado: (2023)

Progressive macular hypomelanosis among Egyptian patients: a clinicopathological study
por: Selim, Mohamed Khaled, et al.
Publicado: (2011)

COVID-19’s effects on the Egyptian population’s brain: Could MRI and specialized MR spectroscopic analysis be beneficial?
por: Reda, Alaa Mohamed, et al.
Publicado: (2022)

Correlation between prediabetes and coronary artery disease severity in patients undergoing elective coronary angiography
por: Muhammed, Ahmed, et al.
Publicado: (2019)

Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia
por: Kosmas, Constantine E., et al.
Publicado: (2018)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients
por: Fadel, Hewida H., et al.
Publicado: (2022)

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Effect of inclisiran on lipids in primary prevention: the ORION-11 trial
por: Ray, Kausik K, et al.
Publicado: (2022)

Effectiveness and safety of Inclisiran in hyperlipidemia treatment: An overview of systematic reviews
por: Li, Jiayi, et al.
Publicado: (2023)

Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy
por: Dec, Adrianna, et al.
Publicado: (2023)

Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary
por: Vohra, Laiba Imran, et al.
Publicado: (2023)

The Prevalence and Risk Factors of Early Arrhythmias Following Pediatric Open Heart Surgery in Egyptian Children
por: Gawad, Tarek Ahmed Abdel, et al.
Publicado: (2017)

What Egyptians think. Knowledge, attitude, and opinions of Egyptian patients towards biobanking issues
por: Abdelhafiz, Ahmed S., et al.
Publicado: (2019)

Molecular Characterization of Eimeria Species Naturally Infecting Egyptian Baldi Chickens
por: GADELHAQ, Sahar M, et al.
Publicado: (2015)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Al-Jabari, Ali Mohammed Kareem, et al.
Publicado: (2017)

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Lipid lowering with inclisiran: a real-world single-centre experience
por: Padam, Pritpal, et al.
Publicado: (2022)

Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus
por: Rakocevic, Jelena, et al.
Publicado: (2023)

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
por: Zhang, Yanzhen, et al.
Publicado: (2023)

Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test
por: Youssef, Mohamed A., et al.
Publicado: (2016)

4D Printing of NiTi Auxetic Structure with Improved Ballistic Performance
por: Hassanin, Hany, et al.
Publicado: (2020)

Microemboli versus hypoperfusion as an etiology of acute ischemic stroke in Egyptian patients with watershed zone infarction
por: ElSadek, Ahmed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_boh2iorc6tdge0se4t1gh71fjb